Lehrstuhl für Kinder- und Jugendmedizin

Prospective, randomized, controlled, multicenter clinical trial on the efficacy and safety of materno-fetal hyperoxygenation (MFHO) during the third trimester of pregnancy to treat underdeveloped left ventricular structures of the fetus July 1, 2022 - June 30, 2027 Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies (SCREEN4CARE) Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies Oct. 1, 2021 - Sept. 30, 2026 J105: Glucose transporter type 1: Metabolic controller of plasma cell longevity and antibody function? Oct. 1, 2023 - March 31, 2026 Non-invasive prenatal diagnosis (NIPD) of XLHED: Cell-free fetal DNA analysis to identify pathogenic EDA variants (KI-SIM_NIPD of XLHED) Jan. 1, 2024 - Dec. 31, 2025 Eine prospektive, offene, durch Genotyp-Paarung kontrollierte klinische Studie zur Erforschung der Wirksamkeit und Sicherheit eines ins Fruchtwasser verabreichten Ektodysplasin-A1-Ersatzproteins als vorgeburtliche Behandlungsmöglichkeit für Jungen mit X-chromosomaler hypohidrotischer ektodermaler Dysplasie (Treat-XLHED) April 1, 2020 - March 31, 2025 PZ_FSM_youngAMBORA (KI-PZ_FSM_youngAMBORA) April 1, 2023 - March 31, 2025 D033: Immunometabolic interplay in pediatric chronic myeloid leukemia: from immunosuppression to synthetic lethality May 16, 2020 - June 30, 2023 P101: VATER/VACTERL association: exome analysis in human and functional studies in zebrafish Jan. 16, 2022 - April 15, 2023 Investigation of possible immune responses to the prenatal administration of recombinant ectodysplasin A1 in patients with hypohidrotic ectodermal dysplasia Jan. 1, 2019 - Sept. 30, 2021 2. Förderphase des Vorhabens: Qualität in Studium und Lehre - QuiS (MF-Quis 2. Förderphase (HiWi)) Jan. 1, 2017 - March 31, 2021